DRC set to receive 70,000 Ebola vaccines, not approved for current strain, WHO says
Last week, the DRC had requested a release of Ervebo vaccines from the global Ebola virus disease vaccine stockpile, managed by the International Coordinating Group (ICG) on Vaccine Provision.
The Democratic Republic of Congo (DRC) will receive 70,000 doses of Merck's Ervebo Ebola vaccine to combat its largest-ever Ebola outbreak, the World Health Organization (WHO) announced. The Ervebo vaccine is approved for the Ebola Zaire strain, but its efficacy against the current Ebola Bundibugyo strain in humans is unknown. Consequently, 20,000 of the allocated doses will be used in a late-stage trial to assess its impact on the Bundibugyo strain. The current outbreak has surpassed previous records, with over 5,000 confirmed cases and 2,378 deaths. WHO Director-General Tedros Ghebreyesus stated that the outbreak in eastern Congo "remains a global emergency."
© All rights to the original article belong to the source. Din Online shows a headline, an excerpt and a link only. The objectivity rating is computed automatically and is an estimate only.
Discussion
No comments yet — be the first to comment.